419 related articles for article (PubMed ID: 8842552)
21. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation.
Fahy JV; Boushey HA
Eur Respir J; 1998 Jun; 11(6):1240-7. PubMed ID: 9657561
[TBL] [Abstract][Full Text] [Related]
22. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements.
Pizzichini E; Pizzichini MM; Efthimiadis A; Evans S; Morris MM; Squillace D; Gleich GJ; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1996 Aug; 154(2 Pt 1):308-17. PubMed ID: 8756799
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment.
Robinson DS; Assoufi B; Durham SR; Kay AB
Clin Exp Allergy; 1995 Nov; 25(11):1118-27. PubMed ID: 8581845
[TBL] [Abstract][Full Text] [Related]
24. Eosinophilic inflammation in asthma.
Bousquet J; Chanez P; Lacoste JY; Barnéon G; Ghavanian N; Enander I; Venge P; Ahlstedt S; Simony-Lafontaine J; Godard P
N Engl J Med; 1990 Oct; 323(15):1033-9. PubMed ID: 2215562
[TBL] [Abstract][Full Text] [Related]
25. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
26. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis.
Koller DY; Nilsson M; Enander I; Venge P; Eichler I
Clin Exp Allergy; 1998 Feb; 28(2):241-8. PubMed ID: 9515599
[TBL] [Abstract][Full Text] [Related]
27. Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma.
Oddera S; Silvestri M; Balbo A; Jovovich BO; Penna R; Crimi E; Rossi GA
Allergy; 1996 Feb; 51(2):100-7. PubMed ID: 8738515
[TBL] [Abstract][Full Text] [Related]
28. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry.
Djukanović R; Wilson JW; Britten KM; Wilson SJ; Walls AF; Roche WR; Howarth PH; Holgate ST
Am Rev Respir Dis; 1990 Oct; 142(4):863-71. PubMed ID: 2221594
[TBL] [Abstract][Full Text] [Related]
29. Eosinophils and eosinophil-derived proteins in children with moderate asthma.
Hoekstra MO; Hovenga H; Gerritsen J; Kauffman HF
Eur Respir J; 1996 Nov; 9(11):2231-5. PubMed ID: 8947065
[TBL] [Abstract][Full Text] [Related]
30. Twenty-four-hour time course of eosinophil granule proteins ECP and EPX during bronchial allergen challenges in serum of asthmatic children.
Niggemann B; Kleinau I; Schmitt M; Wahn U
Allergy; 1994 Feb; 49(2):74-80. PubMed ID: 8172362
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of allergic rhinitis by determining of tryptase and eosinophil cationic protein in nasal secretions].
Rasp G; Bujía J
Acta Otorrinolaringol Esp; 1994; 45(6):437-40. PubMed ID: 7873234
[TBL] [Abstract][Full Text] [Related]
32. Eosinophil cationic protein levels in induced sputum correlate with the severity of bronchial asthma.
Fujimoto K; Kubo K; Matsuzawa Y; Sekiguchi M
Chest; 1997 Nov; 112(5):1241-7. PubMed ID: 9367463
[TBL] [Abstract][Full Text] [Related]
33. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics.
Szczeklik A; Sladek K; Dworski R; Nizankowska E; Soja J; Sheller J; Oates J
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1608-14. PubMed ID: 8970343
[TBL] [Abstract][Full Text] [Related]
34. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma.
Crimi E; Spanevello A; Neri M; Ind PW; Rossi GA; Brusasco V
Am J Respir Crit Care Med; 1998 Jan; 157(1):4-9. PubMed ID: 9445270
[TBL] [Abstract][Full Text] [Related]
35. Spontaneous and induced sputum to measure indices of airway inflammation in asthma.
Pizzichini MM; Popov TA; Efthimiadis A; Hussack P; Evans S; Pizzichini E; Dolovich J; Hargreave FE
Am J Respir Crit Care Med; 1996 Oct; 154(4 Pt 1):866-9. PubMed ID: 8887576
[TBL] [Abstract][Full Text] [Related]
36. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.
Sedgwick JB; Calhoun WJ; Gleich GJ; Kita H; Abrams JS; Schwartz LB; Volovitz B; Ben-Yaakov M; Busse WW
Am Rev Respir Dis; 1991 Dec; 144(6):1274-81. PubMed ID: 1741538
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma.
Ferguson AC; Vaughan R; Brown H; Curtis C
J Allergy Clin Immunol; 1995 Jan; 95(1 Pt 1):23-8. PubMed ID: 7822660
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory mediators in bronchoalveolar lavage samples from children with and without asthma.
Ennis M; Turner G; Schock BC; Stevenson EC; Brown V; Fitch PS; Heaney LG; Taylor R; Shields MD
Clin Exp Allergy; 1999 Mar; 29(3):362-6. PubMed ID: 10202344
[TBL] [Abstract][Full Text] [Related]
39. Eosinophil activity in bronchial asthma.
Venge P
Allergy Proc; 1994; 15(3):139-41. PubMed ID: 7926713
[TBL] [Abstract][Full Text] [Related]
40. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity.
Wardlaw AJ; Dunnette S; Gleich GJ; Collins JV; Kay AB
Am Rev Respir Dis; 1988 Jan; 137(1):62-9. PubMed ID: 2447813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
